U.S. markets closed

NanoVibronix, Inc. (NAOV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.1800+0.0400 (+3.51%)
At close: 4:00PM EST

1.1800 0.00 (0.00%)
After hours: 7:59PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close1.1400
Open1.1500
Bid1.1600 x 1000
Ask1.2000 x 4000
Day's Range1.1500 - 1.2500
52 Week Range0.5350 - 3.5000
Volume1,143,103
Avg. Volume3,947,854
Market Cap22.783M
Beta (5Y Monthly)-0.16
PE Ratio (TTM)N/A
EPS (TTM)-0.6140
Earnings DateNov 16, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Business Wire

    NanoVibronix UroShield Joins PainShield on Federal Supply Schedule, Expanding Access to VA Market

    NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its UroShield urology therapy device has been added to the Federal Supply Schedule through a service disabled veteran organization, thus making it easier for Veterans being treated by the Veterans Administration to secure and utilize the UroShield. On September 1, 2019, NanoVibronix's other proprietary device, the PainShield, was placed on the Federal Supply schedule insuring veterans access to a non-opioid pain therapy.

  • Business Wire

    NanoVibronix Reports Schedule Published by NICE for Review of UroShield® Device

    NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has received documentation from the National Institute for Health and Care Excellence (NICE) that outlines the timeline for NICE’s review and recommendation of the company’s UroShield device.

  • Business Wire

    NanoVibronix Regains Nasdaq Compliance

    NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it received notice from the Nasdaq Listing Qualification Office of The Nasdaq Stock Market LLC ("Nasdaq") on February 2, 2021 that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) ("Min Bid Price Listing Rule").